Literature DB >> 6791681

Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.

R Lombardi, P M Mannucci, M J Seghatchian, V V Garcia, R Coppola.   

Abstract

Factor VIII-related antigen (VIIIR:Ag) was consistently higher than factor-VIII procoagulant activity (VIII:C) in 57 patients with clinical conditions characterized by acute-phase reactions. Two different methods for measuring VIII:C (one- and two-stage assays) and VIIIR:Ag (electroimmunodiffusion and immunoradiometric assay) gave concordant results in the majority of cases. In 43% of plasma samples, crossed immunoelectrophoresis in agarose gel was characterized by the appearance of an additional, fast-moving precipitin peak which was immunologically identical with the major, slower-moving VIIIR:Ag peak. The fast-moving peak was detected in all the patients with clinical conditions typically associated with increased plasma proteolysis (DIC, acute pancreatitis, during thrombolytic therapy). It was present in a smaller proportion of cases with liver and renal failure and malignancies and in the post-operative period. The additional VIIIR:Ag peak is thought to be the result of in vivo factor VIII/von Willebrand factor fragmentation by proteolytic enzymes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791681     DOI: 10.1111/j.1365-2141.1981.tb07197.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

1.  Increased factor VIII/vWf levels in patients with reduced platelet number.

Authors:  A Casonato; F Fabris; M Boscaro; A Girolami
Journal:  Blut       Date:  1987-05

2.  Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis.

Authors:  Philipp A Reuken; Jonathan F Brozat; Alexander Koch; Tony Bruns; Stefanie Quickert; Oluwatomi Ibidapo-Obe; Johanna Reißing; Anika Franz; Sven Stengel; Ulf K-M Teichgräber; Michael Kiehntopf; Christian Trautwein; Andreas Stallmach
Journal:  J Intensive Care       Date:  2022-06-11

3.  The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander.

Authors:  E Macintyre; I J Mackie; D Ho; J Tinker; C Bullen; S J Machin
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

4.  Effects of plasmin on von Willebrand factor multimers. Degradation in vitro and stimulation of release in vivo.

Authors:  K K Hamilton; L J Fretto; D S Grierson; P A McKee
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Studies on platelet surface carbohydrates in normal and uraemic platelets using 125I-labelled lectins.

Authors:  M Manso; I De Dios; L Alberca; V Vicente
Journal:  Blut       Date:  1985-05

6.  Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases.

Authors:  A M Sawyerr; M S Smith; A Hall; M Hudson; C R Hay; A J Wakefield; M G Brook; H Tomura; R E Pounder
Journal:  Dig Dis Sci       Date:  1995-04       Impact factor: 3.199

7.  Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.

Authors:  Thomas J Raife; Wenjing Cao; Bonnie S Atkinson; Bruce Bedell; Robert R Montgomery; Steven R Lentz; George F Johnson; X Long Zheng
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

8.  Haemostatic alterations in malaria correlate to parasitaemia.

Authors:  R D Horstmann; M Dietrich
Journal:  Blut       Date:  1985-11

9.  Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.

Authors:  H-G Topf; E R Strasser; G Breuer; W Rascher; M Rauh; F B Fahlbusch
Journal:  BMC Anesthesiol       Date:  2019-01-10       Impact factor: 2.217

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.